[研究报告] 血管成形术球囊市场预计将从 2022 年的 27.1 亿美元增长到 2030 年的 36 亿美元,2022 年至 2030 年的复合年增长率为 3.6%。
市场洞察和分析师观点:
血管 成形术球囊市场预测可以帮助该市场的利益相关者规划其增长战略。报告包括增长前景,以及预测期内血管成形术球囊市场趋势及其可预见的影响。
血管成形术是一种用于扩张或疏通堵塞冠状动脉并恢复血流的技术。价值型护理注重成本效益和患者治疗效果,正在改变医疗保健行业。与其他可用治疗方法相比,血管成形术球囊能否提供更好的患者治疗效果、降低血运重建率和降低成本,将影响血管成形术球囊市场。与传统外科手术方法相比,血管成形术球囊是一种治疗堵塞动脉的微创方法。随着患者和医务人员越来越倾向于微创手术,对血管成形术球囊的需求也随之上升。心血管疾病发病率的上升和对微创手术的偏好不断增加,这助长了血管成形术球囊市场规模的扩大。然而,与血管成形术相关的并发症阻碍了市场的增长。
增长动力:
心血管疾病患病率上升推动血管成形术球囊市场发展
根据世界卫生组织 (WHO) 的数据,心血管疾病是全球发病率和死亡率的最主要原因。心血管疾病包括脑血管病、冠心病和风湿性心脏病。导致心血管疾病和相关困难的主要生活方式因素包括吸烟、不健康饮食和缺乏运动等。根据美国心脏协会的数据,2020 年记录的心血管疾病相关死亡人数从 2019 年的 874,613 人增加到 928,741 人。2020 年,冠心病是美国心血管疾病死亡的主要原因 (41.2%),其次是中风 (17.3%)、高血压 (12.9%)、心力衰竭 (9.2%)、动脉疾病 (2.6%) 和其他心血管疾病 (16.8%)。此外,世界心脏联盟预测,到 2030 年,每年心血管疾病相关死亡人数将超过 2300 万。
此外,由于吸烟习惯和大量饮酒,尤其是男性,心血管危险因素在中欧和西欧非常普遍。每年有超过 400 万欧洲人死于心血管疾病,主要是冠状动脉疾病和中风。中东地区的心血管疾病发病率也很高,这导致该地区对各种干预措施的需求激增,例如健康教育、生活方式咨询、筛查和治疗。根据世界心脏联盟的数据,心血管疾病是中东和北非地区的主要死亡原因,占所有死亡人数的三分之一以上,每年有 140 万人死于心血管疾病。因此,心血管疾病发病率的上升推动了血管成形术球囊市场的增长。
大多数人认为血管成形术是安全的,但也有报道称手术期间或手术后会出现问题。血栓、心律不齐、血管或心脏瓣膜损伤、中风、对支架材料或药物洗脱支架的过敏反应、支架内再狭窄或支架内部堵塞是血管成形术中涉及的一些风险。虽然其中一些风险极其危险,但其他风险甚至可能是致命的。此外,在某些情况下,患者可能没有足够的时间进行血管成形术。这通常发生在心脏病发作的情况下。所有这些问题都阻碍了血管成形术球囊市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
血管成形术球囊市场分析是通过考虑以下几个部分来进行的:类型、应用和最终用户。
节段分析:
根据类型,血管成形术球囊市场分为普通球囊、药物洗脱球囊、切割球囊和刻划球囊。普通球囊部分在 2022 年占据了最大的市场份额。然而,药物洗脱球囊部分预计将在 2022-2030 年期间实现最高的复合年增长率。
根据应用,血管成形术球囊市场分为外周和冠状动脉。冠状动脉部分在 2022 年占据了更大的血管成形术球囊市场份额,预计在 2022-2030 年期间将录得最高复合年增长率,因为冠状动脉疾病(尤其是心脏病)的患病率不断上升。根据美国疾病控制和预防中心 (CDC) 2023 年 3 月的更新,冠心病是最常见的心脏病类型,影响大约 1/20 的 20 岁及以上人群。然而,外周部分预计在 2022-2030 年期间将录得更高的复合年增长率。
根据最终用户,血管成形术球囊市场分为医院、门诊手术中心和心导管室。医院部分在 2022 年占据了血管成形术球囊的最大市场份额,预计在 2022-2030 年期间将实现最高的复合年增长率。
区域分析:
血管成形术球囊市场报告的地理范围包括北美、欧洲、亚太地区、中东和非洲以及南美和中美。北美在 2022 年占据了最大的市场份额。北美市场的增长受到人口老龄化负担加重、产品发布数量增加以及开发先进血管成形术球囊的研发活动的推动。
血管成形术球囊市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响血管成形术球囊市场的区域趋势和因素。本节还讨论了北美洲、欧洲、亚太地区、中东和非洲以及南美洲和中美洲的血管成形术球囊市场细分和地理分布。
- 获取血管成形术球囊市场的区域特定数据
血管成形术球囊市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 27.1亿美元 |
2030 年的市场规模 | 36亿美元 |
全球复合年增长率(2022 - 2030 年) | 3.6% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
血管成形术球囊市场参与者密度:了解其对业务动态的影响
血管成形术球囊市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在血管成形术球囊市场运营的主要公司有:
- 雅培
- 波士顿科学公司
- 康德乐
- 库克医疗
- CR巴德公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解血管成形术球囊市场顶级关键参与者概况
竞争格局和重点公司:
雅培、波士顿科学公司、康德乐、库克医疗、CR Bard Inc、ENDOCOR GmbH、美敦力、Spectranetics、BIOTRONIK 和 Terumo Medical Corporation 是血管成形术球囊市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球日益增长的消费者需求。根据公司新闻稿,以下是一些最近的关键发展:
- 2023 年 3 月,SIS Medical AG 在美国推出了采用 TWIN-Wall 技术的 OPN NC PTCA 扩张导管。该产品通过提供出色的性能和安全性以及其他球囊失效时的成功率,扩大了治疗的可能性。OPN NC 导管采用 TWIN-Wall 设计,可提供超高耐压性,额定爆破压力为 35 atm,顺应性显著降低。
- 2022 年 9 月,FDA 授予 Advanced NanoTherapies 突破性设备称号 (BDD),用于治疗冠状动脉疾病的 SirPlux Duo 药物涂层球囊 (DCB)。SirPlux Duo DCB 以低剂量长期释放两种化合物来抑制细胞生长,从而产生超过任何其他 DCB 或药物洗脱支架的最大效力。
- 2022 年 1 月,Scoreflex NC 评分 PTCA 导管获得美国食品药品监督管理局 (FDA) 的上市前批准 (PMA)。Scoreflex NC 是一种评分 PTCA 导管,适用于冠状动脉从头狭窄部分和冠状动脉缺血患者的冠状动脉支架内再狭窄,目的是改善心肌灌注。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- High Speed Cable Market
- Artificial Intelligence in Healthcare Diagnosis Market
- Extracellular Matrix Market
- Artwork Management Software Market
- Small Internal Combustion Engine Market
- Diaper Packaging Machine Market
- Hydrogen Storage Alloys Market
- Greens Powder Market
- Dry Eye Products Market
- Piling Machines Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The angioplasty balloonss market, based on end user, is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
Asia Pacific is expected to be the fastest-growing region in the angioplasty balloonss market. The region occupies a significant position in the global angioplasty balloons market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are the increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.
The angioplasty balloonss market, based on application, is is bifurcated into peripheral and coronary. The coronary segment held a larger angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The angioplasty balloonss market, based on type, is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022–2030.
US holds the largest market share in angioplasty balloonss market due to the increasing cases of heart disease. According to the American Heart Association, due to cardiovascular diseases, one person dies every 34 seconds in the US. In 2020, ~697,000 people in the US died from heart disease, i.e., one in every five deaths.
An angioplasty is a technique used to open widen up narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, lower reduced rates of revascularization, and lower costs as compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries. The need for angioplasty balloons is rising as patients and medical professionals show a greater preference for less invasive procedures.
The angioplasty balloonss market majorly consists of players such as Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation among others.
The factors that are driving the growth of the market are the rising prevalence of cardiovascular diseases and rising increasing preference for minimally invasive procedures.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Angioplasty Balloons Market
- Abbott
- Boston Scientific Corporation
- Cardinal Health
- Cook Medical
- C. R. Bard Inc
- ENDOCOR GmbH
- Medtronic
- Spectranetics
- BIOTRONIK
- Terumo Medical Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.